Publications

The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors. Eljilany, I.; Saghand, P.G., et al.

Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers. Spencer R. Rosario, Bowen Dong, et al.

Exploiting Convergent Phenotypes to Derive a Pan-cancer Cisplatin Response Gene Expression Signature. Scarborough JA, Eschrich SA, et al.

A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset. Cankun Wang, Anjun Ma, et al.

The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors. Caroline E. Wheeler, Samuel S. Coleman IV, et al.

Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. Hoskins EL, Samorodnitsky E, et al.

Factors associated with changes in exercise behaviors during the COVID-19 pandemic. Himbert, C., Hathaway, C.A., Daniels, B. et al.

Impact of the COVID-19 pandemic on rural and urban cancer patients’ experiences, health behaviors, and perceptions. Peoples, A. Oswald, L., Ose, J., et al.

Replicative Instability Drives Cancer Progression. Morris BB, Smith JP, Zhang Q, et al.

Factors Predicting Participation in the Prospective Genomic Sequencing Study, Total Cancer Care (TCC), in Kentucky. Riggs MJ, Huang B, Chen Q, et al.